# Observational Neoplasm Metastasis studies: 106 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 106 trials that are observational for Neoplasm Metastasis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Neoplasm Metastasis studies: 106 rows for $5.30, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 5 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/neoplasm-metastasis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 106
- Recruiting or not yet: 106
- Read on: November 19, 2026

## Trials

The 25 newest of 106, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946393 | Preoperative CA 19-9 and the Pattern and Timing of Recurrence After Pancreatoduodenectomy (Whipple Operation) for Pancreatic Cancer | Minia University | Observational | Not yet recruiting | Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946393) |
| November 13, 2026 | NCT07937137 | Liver Tumor Microenvironment Remodeling Promotes Hepatocellular Carcinoma Progression | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Observational | Not yet recruiting | Liver Cancer (Primary and Metastatic) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937137) |
| November 12, 2026 | NCT07933952 | Liver Metastasis in Pancreatic Ductal Adenocarcinoma: Regulatory Mechanisms and Clinical Significance | Nanjing Medical University | Observational | Recruiting | PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Resectable, Pancreatic Adenocarcinoma Metastatic... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933952) |
| November 10, 2026 | NCT07928037 | A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic... | Novartis Pharmaceuticals | Observational | Not yet recruiting | Metastatic Castration-Resistant Prostate Cancer | 2,045 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928037) |
| November 5, 2026 | NCT07920198 | Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient... | Azienda Ospedaliero-Universitaria di Modena | Observational | Recruiting | Cushing s Syndrome, Cushing Disease, Cushing Disease Due to Increased ACTH Secretion, Mild Autonomous Cortisol... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920198) |
| October 29, 2026 | NCT07904494 | Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular... | Assiut University | Observational | Not yet recruiting | Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable, Hepatocellular... | 294 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904494) |
| October 29, 2026 | NCT07904013 | Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis | University Hospital, Bordeaux | Observational | Not yet recruiting | Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Neoplasm Metastasis | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904013) |
| October 28, 2026 | NCT07900984 | A Retrospective Registry of Intelliblate DUAL Channel Microwave Ablation | Varian, a Siemens Healthineers Company | Observational | Not yet recruiting | Liver Ablation, Liver Cancer, Liver Cancer (Primary and Metastatic) | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900984) |
| October 27, 2026 | NCT07899463 | ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek Population | Hellenic Cooperative Oncology Group | Observational | Recruiting | ESR1 Gene Mutation, Breast Cancer (Locally Advanced or Metastatic), Hormon Receptor Positive Breast Cancer | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899463) |
| October 7, 2026 | NCT07863986 | Predictive Factors for Response to Lutetium-177 PSMA Radioligand Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer | Lithuanian University of Health Sciences | Observational | Recruiting | Prostate Cancer, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Neoplasm Metastases | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863986) |
| October 6, 2026 | NCT07860866 | Blood Biomarkers for Breast Cancer Treatment Response | University of Pittsburgh | Observational | Not yet recruiting | Breast Cancer (Advanced/Metastatic), ER Positive | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860866) |
| September 30, 2026 | NCT07850882 | A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for... | Sponsor not shown (see the record) | Observational | Recruiting | Colorectal Cancer (CRC), Gastric Cancer (GC), Hepatocellular Carcinoma (HCC) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850882) |
| September 30, 2026 | NCT07850869 | A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced... | Sponsor not shown (see the record) | Observational | Recruiting | Breast Cancer (Locally Advanced or Metastatic) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850869) |
| September 30, 2026 | NCT07848516 | Change in Fat Fraction Quantification Before and After Treatment in Bone Metastases | Assiut University | Observational | Recruiting | Neoplasm Metastasis / Bone and Bones | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848516) |
| September 17, 2026 | NCT07824791 | Prediction of Postoperative Recurrence in Crohn's Disease | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Recruiting | Crohn Disease (CD), Postoperative Recurrence and Metastasis | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824791) |
| September 15, 2026 | NCT07820644 | A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease) | Sponsor not shown (see the record) | Observational | Recruiting | Liver Cancer (Primary and Metastatic) | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820644) |
| September 4, 2026 | NCT07804875 | Symptom Trajectory Approaches to Research | University of Wisconsin, Madison | Observational | Not yet recruiting | Advanced Cancer, Metastatic Disease, Cancer Treatment, Progressive Disease, Recurrent Cancer | 228 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804875) |
| September 2, 2026 | NCT07799974 | Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a... | University Hospital, Ghent | Observational | Recruiting | Lung Cancer (Locally Advanced or Metastatic) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799974) |
| September 1, 2026 | NCT07797387 | Pelvic Floor Ultrasound Before Induction of Labour and Labour Outcome | University of Roma La Sapienza | Observational | Not yet recruiting | Labor, Pelvic Floor Disorder, Labor Stage, Second, Induced Labor, Pelvic Floor, Levator Ani Muscle Injury | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797387) |
| August 19, 2026 | NCT07773285 | Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer... | Latin American Cooperative Oncology Group | Observational | Recruiting | Solid Tumor, Metastatic Solid Tumor, Recurrent Solid Tumor | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773285) |
| July 13, 2026 | NCT07697989 | Pluvicto Real-world Investigation in Survival in Metastatic CRPC | Novartis Pharmaceuticals | Observational | Recruiting | Prostatic Neoplasms, Castration-Resistant, Neoplasm Metastasis | 1,085 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697989) |
| July 10, 2026 | NCT07696832 | Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or... | Guangdong Association of Clinical Trials | Observational | Recruiting | Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC, EGFR... | 265 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696832) |
| June 22, 2026 | NCT07659652 | Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease | University of California, San Francisco | Observational | Not yet recruiting | Breast Cancer, Quality of Life, Breast Cancer, Metastatic, Breast Cancer, Metastatic Breast Cancer, Leptomeningeal... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07659652) |
| June 17, 2026 | NCT07653893 | A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab... | Fudan University | Observational | Recruiting | Central Nervous System (CNS) Metastases, Breast Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653893) |
| June 9, 2026 | NCT07636148 | Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance | Sponsor not shown (see the record) | Observational | Recruiting | Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor, Kidney... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636148) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assiut University | 4 |
| Mayo Clinic | 3 |
| University Health Network, Toronto | 3 |
| Tianjin Medical University | 3 |
| Yunnan Cancer Hospital | 3 |
| Indiana University | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| M.D. Anderson Cancer Center | 2 |
| University of Maryland, Baltimore | 2 |
| Fudan University | 2 |
| University Hospital Augsburg | 1 |
| Latin American Cooperative Oncology Group | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Alpha Biopharma (Jiangsu) Co., Ltd. | 1 |
| Chinese University of Hong Kong | 1 |
| Hellenic Cooperative Oncology Group | 1 |
| RenJi Hospital | 1 |
| I.M. Sechenov First Moscow State Medical University | 1 |
| Santa Chiara Hospital | 1 |
| Huazhong University of Science and Technology | 1 |
| Zhongnan Hospital | 1 |
| European Institute of Oncology | 1 |
| National Cancer Institute LAO | 1 |
| Tongji Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 26 |
| United States | 24 |
| Italy | 11 |
| France | 7 |
| Spain | 5 |
| Netherlands | 4 |
| Germany | 3 |
| Canada | 3 |
| Egypt | 3 |
| Brazil | 2 |
| Turkey (Türkiye) | 2 |
| Belgium | 2 |
| Hong Kong | 1 |
| Greece | 1 |
| India | 1 |
| Vietnam | 1 |
| United Kingdom | 1 |
| Puerto Rico | 1 |
| Switzerland | 1 |
| South Korea | 1 |
| Lithuania | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Banks and credit unions in the United States](https://specstream.ai/data/businesses/banks-and-credit-unions/united-states)
- [Industrial cleaning companies in the United States](https://specstream.ai/data/businesses/industrial-cleaning-companies/united-states)
- [Taco restaurants in the United States](https://specstream.ai/data/businesses/taco-restaurants/united-states)
- [Debt relief companies in the United States](https://specstream.ai/data/businesses/debt-relief-companies/united-states)
- [Office cleaning companies in the United States](https://specstream.ai/data/businesses/office-cleaning-companies/united-states)
- [Appliance manufacturers in the United States](https://specstream.ai/data/businesses/appliance-manufacturers/united-states)
